James P. Basilion

James P. Basilion is a Professor at Case Western Reserve University, holding dual appointments in the Department of Biomedical Engineering (Case School of Engineering) and the Department of Radiology (School of Medicine). He serves as Co-Leader of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His expertise lies in molecular imaging and theranostics, focusing on developing imaging agents and therapies targeting cancer biomarkers, particularly prostate and breast cancers. Dr. Basilion earned his PhD in Pharmacology from The University of Texas at Houston and a BA in Biochemistry from the University of Pennsylvania.

Research interests include molecular imaging technologies, targeted nanoparticles, and protease-activatable imaging agents for surgical guidance. His work combines engineering, radiology, and oncology to enhance diagnostic precision and treatment efficacy. Notable contributions include advancements in PSMA-targeted therapies and ultrasound-based nanobubble contrast agents.

Awards include the 2013 Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research, and recognition as a Fellow of the American Institute for Medical and Biomedical Engineering (2014). He has held leadership roles in organizations like the World Molecular Imaging Society and the American Academy of Nanomedicine.

His research spans over 120 publications, emphasizing cancer imaging innovations, nanotechnology applications, and translational medicine. Active in professional societies, he contributes to advancing molecular imaging standards and technologies.